Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

Will My Child Inherit PKU If I Have It?

At a Glance

Your child will only inherit PKU if your partner is a carrier or also has the condition. If your partner is not a carrier, your child will not have PKU. However, pregnant women with PKU must strictly control their phenylalanine levels to prevent Maternal PKU Syndrome and protect the baby's health.

If you have Phenylketonuria (PKU), your child will only be born with the condition if your partner is a carrier of the PKU gene (or also has PKU). Because PKU is a recessive genetic trait, it takes two copies of the non-working gene—one from each parent—for a child to have the condition [1][2]. If your partner does not carry the gene, your child will not have PKU, but they will definitely be a carrier.

For women with PKU (and anyone with PKU who can become pregnant) planning a family, it is very important to understand the difference between a child inheriting PKU through genetics and a child being affected by Maternal PKU Syndrome, which is caused by the mother’s blood phenylalanine (Phe) levels during pregnancy.

How PKU is Inherited

PKU is an autosomal recessive condition [1]. This means that the gene responsible for producing the phenylalanine hydroxylase (PAH) enzyme is non-working, and a person must inherit two copies of this non-working gene to have PKU. Because you have PKU, you will definitely pass one copy of the non-working gene to your child.

Your baby’s chance of having PKU depends entirely on your partner’s genetics:

  • If your partner is not a carrier: Your baby has a 0% chance of having PKU. However, they have a 100% chance of being a carrier (inheriting one working gene from your partner and one non-working gene from you). Carriers do not have symptoms of PKU.
  • If your partner is a carrier: Your baby has a 50% chance of being born with PKU, and a 50% chance of being a carrier.
  • If your partner also has PKU: Your baby has a 100% chance of having PKU.

If you are planning to have a child, your partner can undergo genetic testing to find out if they carry the mutated PAH gene. Standard over-the-counter tests may not detect all variants, so it is best to have a comprehensive blood or saliva test ordered by a doctor or genetic counselor.

Understanding Maternal PKU Syndrome

While genetic inheritance determines whether your baby will have PKU, there is a separate and serious concern for pregnant individuals with PKU known as Maternal PKU Syndrome.

Maternal PKU Syndrome is not a genetic condition the baby inherits. Instead, it is a condition caused by the environment in the womb [3][4]. If a pregnant person with PKU has elevated levels of phenylalanine in their blood, the high Phe levels cross the placenta and act as a teratogen (a substance that can cause birth defects) [5][6].

Exposure to high maternal Phe levels can cause serious complications for the developing fetus, regardless of whether the baby inherited the genes for PKU. While reading this list can be frightening, it is important to remember that these risks are linked to uncontrolled Phe levels, not simply having PKU. If levels are too high, the risks include:

  • Microcephaly (abnormally small head size) [7][8]
  • Congenital heart defects [9][10]
  • Intrauterine growth restriction (poor growth in the womb) [8]
  • Intellectual disability and developmental delays [9][10]

Preventing Maternal PKU Syndrome

The good news is that Maternal PKU Syndrome is entirely preventable. To protect the developing baby, doctors recommend strictly managing your blood phenylalanine levels, keeping them within a tight target range of 120-360 µmol/L [11][12].

Because the baby’s vital organs develop very early in pregnancy, it is highly recommended to use effective birth control until your blood Phe levels are consistently within this safe target range for a period of time recommended by your doctor. You will need to maintain this strict control before conception and throughout the entire pregnancy [13][14].

Returning to the strict PKU diet as an adult can be incredibly difficult, both practically and emotionally. You do not have to do it alone—metabolic clinics have dietitians and psychologists who can help you transition. Furthermore, preventing Maternal PKU Syndrome isn’t just about food. If you take PKU medications (such as sapropterin/Kuvan or pegvaliase/Palynziq), you must discuss your prescriptions with your metabolic specialist before trying to conceive, as your medication regimen may need to be adjusted, paused, or monitored through specific pregnancy registries.

Common questions in this guide

Will my baby be born with PKU if my partner doesn't have it?
If your partner is not a carrier of the PKU gene, your baby will not have PKU. However, because you have PKU, your child will definitely inherit one non-working gene from you and be a carrier of the condition. Carriers do not experience any symptoms.
What is Maternal PKU Syndrome?
Maternal PKU Syndrome is a condition that occurs when a pregnant person with PKU has high blood phenylalanine levels. These high levels cross the placenta and act as a teratogen, which can cause serious birth defects and developmental delays in the baby, even if the baby does not inherit PKU.
How can I prevent Maternal PKU Syndrome?
You can prevent Maternal PKU Syndrome by keeping your blood phenylalanine levels strictly controlled within a safe target range before conceiving and throughout your entire pregnancy. This usually requires strict adherence to a PKU diet and close monitoring by your metabolic healthcare team.
Does my partner need genetic testing for PKU?
Yes, if you have PKU and are planning a family, your partner should undergo comprehensive genetic carrier screening. Standard over-the-counter tests may miss some variants, so a doctor or genetic counselor should order the test to accurately determine the chances of your child inheriting PKU.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific blood phenylalanine range should I aim for, and for how long, before I stop using birth control?
  2. 2.If I am currently taking PKU medications (such as sapropterin or pegvaliase), how do we need to adjust or pause my treatment plan for pregnancy?
  3. 3.How frequently will I need to submit blood spots to monitor my Phe levels while trying to conceive and during the pregnancy?
  4. 4.Can you refer my partner for comprehensive genetic carrier screening for the PAH gene?
  5. 5.What practical and emotional support can the metabolic clinic provide if I struggle to maintain the strict diet?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Genetic etiology and clinical challenges of phenylketonuria.

    Elhawary NA, AlJahdali IA, Abumansour IS, et al.

    Human genomics 2022; (16(1)):22 doi:10.1186/s40246-022-00398-9.

    PMID: 35854334
  2. 2

    Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses.

    Ferreira F, Azevedo L, Neiva R, et al.

    Molecular genetics & genomic medicine 2021; (9(3)):e1559 doi:10.1002/mgg3.1559.

    PMID: 33465300
  3. 3

    Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman.

    Alghamdi MA, O'Donnell-Luria A, Almontashiri NA, et al.

    JIMD reports 2023; (64(5)):312-316 doi:10.1002/jmd2.12384.

    PMID: 37701331
  4. 4

    AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria.

    Richards DY, Winn SR, Dudley S, et al.

    Molecular therapy. Methods & clinical development 2020; (17()):234-245 doi:10.1016/j.omtm.2019.12.004.

    PMID: 31970201
  5. 5

    A phenylalanine-free recombinant nutritional protein for the dietary management of phenylketonuria.

    Mücke Y, Jablonka N, Rimann N, et al.

    Journal of inherited metabolic disease 2024; (47(4)):651-663 doi:10.1002/jimd.12719.

    PMID: 38390655
  6. 6

    Neurotoxicity of phenylalanine on human iPSC-derived cerebral organoids.

    Kim J, Lee S, Lee J, et al.

    Molecular genetics and metabolism 2022; (136(2)):132-144 doi:10.1016/j.ymgme.2022.04.005.

    PMID: 35562278
  7. 7

    Maternal Phenylketonuria: Consequences of Dietary Non-Adherence and Gaps in Preconception Care-A Case Report.

    Donarska J, Szablewska AW, Wierzba J

    Journal of clinical medicine 2025; (14(4)) doi:10.3390/jcm14041102.

    PMID: 40004633
  8. 8

    Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.

    Yıldız Y, Sivri HS

    European journal of pediatrics 2019; (178(7)):1005-1011 doi:10.1007/s00431-019-03387-8.

    PMID: 31053953
  9. 9

    Partial hydatidiform mole in a phenylketonuria patient treated with sapropterin dihydrochloride.

    Yildiz Y, Dursun A, Tokatli A, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2017; (33(1)):19-20 doi:10.1080/09513590.2016.1247796.

    PMID: 27898272
  10. 10

    Maternal Phenylketonuria and Offspring Outcome: A Retrospective Study with a Systematic Review of the Literature.

    Leone G, Meli C, Falsaperla R, et al.

    Nutrients 2025; (17(4)) doi:10.3390/nu17040678.

    PMID: 40005006
  11. 11

    Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.

    Zeile WL, McCune HC, Musson DG, et al.

    Pediatric research 2018; (83(4)):889-896 doi:10.1038/pr.2017.323.

    PMID: 29278642
  12. 12

    Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuria.

    Grohmann-Held K, Burgard P, Baerwald CGO, et al.

    Journal of inherited metabolic disease 2022; (45(6)):1070-1081 doi:10.1002/jimd.12544.

    PMID: 36054426
  13. 13

    Key European guidelines for the diagnosis and management of patients with phenylketonuria.

    van Spronsen FJ, van Wegberg AM, Ahring K, et al.

    The lancet. Diabetes & endocrinology 2017; (5(9)):743-756 doi:10.1016/S2213-8587(16)30320-5.

    PMID: 28082082
  14. 14

    The Light and the Dark Side of Maternal PKU: Single-Centre Experience of Dietary Management and Emergency Treatment Protocol of Unplanned Pregnancies.

    Gautiero C, Scala I, Esposito G, et al.

    Nutrients 2025; (17(6)) doi:10.3390/nu17061048.

    PMID: 40292461

This page is for informational purposes only and does not replace professional medical advice. Always consult your genetics team and maternal-fetal specialist regarding family planning and managing PKU during pregnancy.

Get notified when new evidence is published on Phenylketonuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.